Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2013

01-03-2013 | General Gynecology

Aberrant histone acetylation and methylation levels in woman with endometriosis

Published in: Archives of Gynecology and Obstetrics | Issue 3/2013

Login to get access

Abstract

Objective

To investigate the alterations in histone modifications in woman with endometriosis.

Methods

Global histone H3/H4 acetylation and H3K4/H3K9 methylation in eutopic and ectopic endometrium from 15 endometriosis patients were assayed using the EpiQuik™ global histone H3/H4 acetylation and H3K4/H3K9 methylation assay kits. Quantitative real-time reverse transcriptase-polymerase chain reaction was applied to measure mRNA levels of 12 members of histone-related chromatin modifier genes.

Results

Histone H4 hypoacetylation was detected both in eutopic and ectopic endometrium. There were no difference between patients with endometriosis and controls on global levels of H3 acetylation. Furthermore, global histone H3K4 hypomethylation and H3K9 hypomethylation were detected both in ectopic and eutopic endometrium (p < 0.001), and in ectopic endometrium (p < 0.001), respectively. SIRT1 mRNA level was significantly decreased in eutopic endometrium, while mRNA levels of HDAC1, SUV39H1, SUV39H2 and G9a were significantly downregulated in ectopic endometrium. HDAC2 mRNA level was significantly increased in eutopic endometrium. PCAF mRNA level was significantly increased in ectopic endometrium.

Conclusions

Aberrant histone modification may play an important role in the pathogenesis of endometriosis.
Literature
2.
go back to reference Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258PubMedCrossRef Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258PubMedCrossRef
3.
go back to reference Wheeler JM (1989) Epidemiology of endometriosis-associated infertility. J Reprod Med 34:41–46PubMed Wheeler JM (1989) Epidemiology of endometriosis-associated infertility. J Reprod Med 34:41–46PubMed
4.
go back to reference Gurates B, Bulun SE (2003) Endometriosis: the ultimate hormonal disease. Semin Reprod Med 21:125–134PubMedCrossRef Gurates B, Bulun SE (2003) Endometriosis: the ultimate hormonal disease. Semin Reprod Med 21:125–134PubMedCrossRef
5.
go back to reference Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S (2002) Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 955:75–85 (discussion 86–88, 396–406)PubMedCrossRef Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S (2002) Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 955:75–85 (discussion 86–88, 396–406)PubMedCrossRef
6.
go back to reference Paul DW, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18:245–263CrossRef Paul DW, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18:245–263CrossRef
7.
go back to reference Ulukus M, Arici A (2005) Immunology of endometriosis. Minerva Ginecol 57:237–248PubMed Ulukus M, Arici A (2005) Immunology of endometriosis. Minerva Ginecol 57:237–248PubMed
8.
go back to reference Barlow DH, Kennedy S (2005) Endometriosis: new genetic approaches and therapy. Annu Rev Med 56:345–356PubMedCrossRef Barlow DH, Kennedy S (2005) Endometriosis: new genetic approaches and therapy. Annu Rev Med 56:345–356PubMedCrossRef
9.
go back to reference Simpson JL, Bischoff FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30:21–40PubMedCrossRef Simpson JL, Bischoff FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30:21–40PubMedCrossRef
10.
go back to reference Rier SE (2002) The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 955:201–212 (discussion 230–2, 396–406)PubMedCrossRef Rier SE (2002) The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 955:201–212 (discussion 230–2, 396–406)PubMedCrossRef
12.
go back to reference Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174:341–348PubMed Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174:341–348PubMed
13.
go back to reference Vialou V (2010) Histone acetylation, gene regulation and depression. Med Sci (Paris) 26:465–467CrossRef Vialou V (2010) Histone acetylation, gene regulation and depression. Med Sci (Paris) 26:465–467CrossRef
14.
go back to reference Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE, Groudine M (2000) Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20:9103–9112PubMedCrossRef Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE, Groudine M (2000) Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20:9103–9112PubMedCrossRef
15.
17.
go back to reference Verdone L, Agricola E, Caserta M, Di Mauro E (2006) Histone acetylation in gene regulation. Brief Funct Genomic Proteomic 5:209–221PubMedCrossRef Verdone L, Agricola E, Caserta M, Di Mauro E (2006) Histone acetylation in gene regulation. Brief Funct Genomic Proteomic 5:209–221PubMedCrossRef
18.
go back to reference Wu Y, Strawn E, Basir Z, Halverson G, Guo SW (2007) Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87:24–32PubMedCrossRef Wu Y, Strawn E, Basir Z, Halverson G, Guo SW (2007) Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87:24–32PubMedCrossRef
19.
go back to reference Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW (2005) Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193:371–380PubMedCrossRef Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW (2005) Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193:371–380PubMedCrossRef
20.
go back to reference Yang J, Fang X (2012) Expression of DNMT1, DNMT3a, and DNMT3b in eutopic endometrium. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37:94–99PubMed Yang J, Fang X (2012) Expression of DNMT1, DNMT3a, and DNMT3b in eutopic endometrium. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37:94–99PubMed
21.
go back to reference Li JX, Liu HL (2004) The relationship of DNA methylation and histone methylation. Yi Chuan 26:267–270PubMed Li JX, Liu HL (2004) The relationship of DNA methylation and histone methylation. Yi Chuan 26:267–270PubMed
22.
23.
go back to reference Ebert A, Lein S, Schotta G, Reuter G (2006) Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosom Res 14:377–392CrossRef Ebert A, Lein S, Schotta G, Reuter G (2006) Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosom Res 14:377–392CrossRef
24.
go back to reference Bird A (2001) Molecular biology. Methylation talk between histones and DNA. Science 294:2113–2115PubMedCrossRef Bird A (2001) Molecular biology. Methylation talk between histones and DNA. Science 294:2113–2115PubMedCrossRef
25.
go back to reference Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15–30PubMedCrossRef Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15–30PubMedCrossRef
26.
go back to reference Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF, Gozani O (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442:96–99PubMedCrossRef Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF, Gozani O (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442:96–99PubMedCrossRef
27.
go back to reference Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12:1591–1598PubMedCrossRef Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12:1591–1598PubMedCrossRef
28.
go back to reference Eskeland R, Eberharter A, Imhof A (2007) HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol 27:453–465PubMedCrossRef Eskeland R, Eberharter A, Imhof A (2007) HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol 27:453–465PubMedCrossRef
29.
go back to reference Smallwood A, Esteve PO, Pradhan S, Carey M (2007) Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 21:1169–1178PubMedCrossRef Smallwood A, Esteve PO, Pradhan S, Carey M (2007) Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 21:1169–1178PubMedCrossRef
30.
go back to reference Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192–1200PubMedCrossRef Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192–1200PubMedCrossRef
31.
go back to reference Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381–2402PubMedCrossRef Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381–2402PubMedCrossRef
32.
go back to reference Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Updat 12:77–89CrossRef Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Updat 12:77–89CrossRef
33.
go back to reference Vigushin DM, Coombes RC (2002) Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1–13PubMedCrossRef Vigushin DM, Coombes RC (2002) Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1–13PubMedCrossRef
34.
go back to reference Mahlknecht U, Hoelzer D (2000) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6:623–644PubMed Mahlknecht U, Hoelzer D (2000) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6:623–644PubMed
35.
go back to reference Kawano Y, Nasu K, Li H, Tsuno A, Abe W, Takai N, Narahara H (2011) Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26:2486–2498PubMedCrossRef Kawano Y, Nasu K, Li H, Tsuno A, Abe W, Takai N, Narahara H (2011) Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26:2486–2498PubMedCrossRef
36.
go back to reference Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ (2004) Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 10:5271–5281PubMedCrossRef Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ (2004) Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 10:5271–5281PubMedCrossRef
37.
go back to reference Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38–51PubMedCrossRef Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38–51PubMedCrossRef
38.
go back to reference Colon-Diaz M, Baez-Vega P, Garcia M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, Flores I (2012) HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci 19:483–492PubMedCrossRef Colon-Diaz M, Baez-Vega P, Garcia M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, Flores I (2012) HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci 19:483–492PubMedCrossRef
39.
go back to reference Imesch P, Samartzis EP, Schneider M, Fink D, Fedier A (2011) Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertil Steril 95:1579–1583PubMedCrossRef Imesch P, Samartzis EP, Schneider M, Fink D, Fedier A (2011) Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertil Steril 95:1579–1583PubMedCrossRef
40.
go back to reference Imesch P, Fink D, Fedier A (2010) Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril 94:2838–2842PubMedCrossRef Imesch P, Fink D, Fedier A (2010) Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril 94:2838–2842PubMedCrossRef
41.
go back to reference Trapp J, Jung M (2006) The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targ 7:1553–1560CrossRef Trapp J, Jung M (2006) The role of NAD+ dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targ 7:1553–1560CrossRef
42.
go back to reference Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67–76PubMedCrossRef Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67–76PubMedCrossRef
43.
go back to reference Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148PubMedCrossRef Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148PubMedCrossRef
44.
go back to reference Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappa B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380PubMedCrossRef Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappa B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380PubMedCrossRef
45.
go back to reference Defrere S, Gonzalez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, Van Langendonckt A (2011) Insights into iron and nuclear factor-kappa B (NF-kappa B) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 26:1083–1092PubMed Defrere S, Gonzalez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, Van Langendonckt A (2011) Insights into iron and nuclear factor-kappa B (NF-kappa B) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 26:1083–1092PubMed
Metadata
Title
Aberrant histone acetylation and methylation levels in woman with endometriosis
Publication date
01-03-2013
Published in
Archives of Gynecology and Obstetrics / Issue 3/2013
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2591-0

Other articles of this Issue 3/2013

Archives of Gynecology and Obstetrics 3/2013 Go to the issue